Search for: "ALZA CORP V MYLAN LAB" Results 1 - 16 of 16
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 May 2019, 11:24 am by Lawrence B. Ebert
Cir. 2014)(quoting Alza Corp. v. [read post]
29 Dec 2010, 2:57 am by Marie Louise
– FDA again seeking to restrict marketing of unapproved animal drugs (FDA Law Blog) US: Notorious affiliate exclusion provision of PPACA repealed (FDA Law Blog) US: Cephalon’s gambit in pay-to-delay (IPBiz) US: Labcorp’s failed patent re-examination challenge at issue in contract dispute: Lab Corp. of Am. [read post]
4 Aug 2015, 11:27 am by Lawrence B. Ebert
Gypsum Co., 333U.S. 364, 395 (1948); Alza Corp. v. [read post]
25 Mar 2011, 11:43 am by Lawrence B. Ebert
Cir. 2007), or even guarantee success, see Alza Corp. v. [read post]
30 Apr 2007, 4:50 pm
  Thus, any advantage that the combination may provide may also suggest an "‘implicit[]'" motivation to make the combination, Slip op. at 18 (quoting Alza Corp. v. [read post]
30 Apr 2007, 10:51 am
Thus, any advantage that the combination may provide may also suggest an "‘implicit[]'" motivation to make the combination, Slip op. at 18 (quoting Alza Corp. v. [read post]
25 Mar 2011, 8:29 pm
Cir. 2007), or even guarantee success, see Alza Corp. v. [read post]
11 Jun 2007, 10:15 pm
Patrick Co., 464 F.3d 1356 (2006) and Alza Corp. v. [read post]
30 Nov 2006, 10:11 am
Mylan Labs., Inc., and Dystar Textilfarben GmbH v. [read post]
22 Jul 2010, 8:15 pm
See, e.g., Alza Corp. v. [read post]